Novel method for analysing phenotypic characteristics of human immunodeficiency virus (HIV)

Details for Australian Patent Application No. 2002223052 (hide)

International Classifications

Event Publications

29 January 2004 Section 223 Application Received

Inserm; Bioalliance Pharma An application to extend the time from 10 Jun 2003 to 10 Nov 2003 in which to file a verified translation has been filed . Address for service in Australia - Griffith Hack GPO Box 1285K MELBOURNE VIC 3001

25 March 2004 Section 223 Application Allowed

Inserm; Bioalliance Pharma The time in which to file a verified translation has been extended to 10 Nov 2003. Address for service in Australia - Griffith Hack GPO Box 1285K MELBOURNE VIC 3001

26 July 2007 Assignment before Grant

Bioalliance Pharma; Inserm The application has been assigned to Inserm; Eurofins viralliance, Inc.

20 September 2007 Application Accepted

Published as AU-B-2002223052

24 January 2008 Standard Patent Sealed

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.